Work

The Bonebridge Active Bone Conduction Hearing Implant: Safety, Effectiveness and Outcomes Based on 355 Patients

Year: 2025

Type: article

Abstract: OBJECTIVES: This study evaluates the safety and efficacy of the Bonebridge BCI 601 and 602 bone conduction implants in our largest cohort to date of 355 patients. The patients had a wide age range and exhibited conductive, mixed, or single-sided deafness (SSD). DESIGN: All patients underwent Bonebridge implantation. Pre- and post-implantation evaluations included pure-tone audiometry, speech recognition tests, and free-field audiometry. Word recognition was measured using the Polish Monosyllabic Word Test, while speech reception in noise was assessed using the Polish Sentence Matrix Test. Subjective benefit was assessed using the APHAB questionnaire. Follow-up tests were performed 3-6 months after activation. RESULTS: Revision surgery was required in 17 patients (4.8%) due to complications, including implant removal in 5 cases. Reimplantation was successful in 4 of these. The APHAB questionnaire showed improved hearing function and all hearing tests also showed significant improvement. CONCLUSION: Active bone conduction implantation is an effective method for the rehabilitation of conductive hearing loss, mixed hearing loss, and unilateral deafness. This large cohort study confirms significant hearing improvement and subjective benefits. The low complication rate supports the reliability of the Bonebridge system.

Source: Clinical Otolaryngology

DOI: 10.1111/coa.70050

Authors: Piotr Henryk Skarzynski, Katarzyna Beata Cywka, Emilia Anna Czaplicka, Henryk Skarzynski

Institution: Institute of Physiology and Pathology of Hearing

Language: English

Topic: Hearing Loss and Rehabilitation

Subfield: Cognitive Neuroscience

Field: Neuroscience

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $4,520